| Literature DB >> 35055063 |
Chuwei Lin1,2, Aneirin Alan Lott1,2,3, Wei Zhu1,4, Craig P Dufresne5, Sixue Chen1,2,3,6.
Abstract
Mitogen-activated protein kinase 4 (MPK4) was first identified as a negative regulator of systemic acquired resistance. It is also an important kinase involved in many other biological processes in plants, including cytokinesis, reproduction, and photosynthesis. Arabidopsis thaliana mpk4 mutant is dwarf and sterile. Previous omics studies including genomics, transcriptomics, and proteomics have revealed new functions of MPK4 in different biological processes. However, due to challenges in metabolomics, no study has touched upon the metabolomic profiles of the mpk4 mutant. What metabolites and metabolic pathways are potentially regulated by MPK4 are not known. Metabolites are crucial components of plants, and they play important roles in plant growth and development, signaling, and defense. Here we used targeted and untargeted metabolomics to profile metabolites in the wild type and the mpk4 mutant. We found that in addition to the jasmonic acid and salicylic acid pathways, MPK4 is involved in polyamine synthesis and photosynthesis. In addition, we also conducted label-free proteomics of the two genotypes. The integration of metabolomics and proteomics data allows for an insight into the metabolomic networks that are potentially regulated by MPK4.Entities:
Keywords: Arabidopsis thaliana; cytokinesis; immunity; metabolomics and proteomics; mitogen-activated protein kinase 4; polyamine metabolic networks
Mesh:
Substances:
Year: 2022 PMID: 35055063 PMCID: PMC8779387 DOI: 10.3390/ijms23020880
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Morphological phenotype and transcript analysis of mpk4. (A) 5-week-old Arabidopsis thaliana wild-type (WT) (left) and mpk4 mutant (right). (B) Semi-qPCR result showing abundant MPK4 transcript in WT, but none in the mpk4 mutant.
Figure 2Comparison of metabolomics data from three different mass spectrometry platforms. (A) Venn diagram showing overlap of identified metabolites from targeted (4000 QTRAP) and untargeted metabolomics (timsTOF and Orbitrap). (B) coefficient of variance (CV%) of the quantitative data from the three platforms. (C) timsTOF data composition. (D) Orbitrap data composition. MS1 indicates features only have MS1 spectra and do not have annotation; MS2 indicates features have both MS1 and MS2 spectra but no annotation; annotation indicates those metabolites with both MS1 and MS2 spectra, and annotated with names and chemical formulars.
Figure 3Metabolomics data analysis of WT and mpk4 mutant. (A) PCA analysis showing distinct separation of WT and the mpk4. (B) Volcano plot. FC (fold change) = metabolite abundance in mpk4/WT. (C) KEGG metabolic pathway impact analysis. 1: linoleic acid metabolism; 2: isoquinoline alkaloid biosynthesis; 3: phenylalanine metabolism; 4: alpha-linolenic acid metabolism; 5: citrate cycle; 6: glyoxylate and dicarboxylate metabolism; 7: arginine and proline metabolism; 8: tyrosine metabolism. The size of the dot indicates pathway impact factor; color of dots from light yellow to red indicates—log10 (p) from small to large. (D) KEGG enrichment analysis of eight significant pathways.
Figure 4Pathways with differential metabolites and proteins between WT and the mpk4 mutant. (A) Linoleic acid metabolism. (B) Tyrosine metabolism. (C) Phenylalanine metabolism. (D) Alpha-Linolenic acid metabolism. (E) Citrate cycle. (F) Arginine and proline metabolism. (G) Salicylic acid synthesis. red: increased in mpk4; green: decreased in mpk4; solid arrow: direct reaction; dotted arrow: multiple reaction steps.
Figure 5Proteomics data analysis of WT and the mpk4 mutant. (A) PCA analysis. (B) Volcano plot. FC (fold change) = protein level in mpk4/WT. (C) KEGG pathway enrichment analysis. (D) GO biological process. (E) GO molecular function. (F) GO cellular component.
Figure 6Integrated metabolite and protein network shown in KEGG pathways. (A) All metabolites and proteins found in samples are shown in KEGG pathway map. Dots indicate metabolites and lines indicate proteins. (B) Metabolites and proteins with significant changes (>twofold and p < 0.05) are shown in KEGG pathway map. Green indicates decreased in the mpk4 and red indicates increased in the mpk4. Please refer to Figure S1 for a high-resolution version of the pathways.